Quantum Biopharma (QNTM) Inventory Average (2025 - 2026)
Quantum Biopharma (QNTM) reported Inventory Average of $51800.5 for Q1 2026, down 50.92% on a YoY basis from $105549.0 in Q1 2025, and down 20.16% sequentially from $64877.5 in Q4 2025.
Quantum Biopharma (QNTM) Inventory Average (2025 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 2 years of Inventory Average data on file, last reported at $51800.5 in Q1 2026.
- For the quarter ending Q1 2026, Inventory Average fell 50.92% year-over-year to $51800.5; the trailing twelve-month figure through Mar 2026 stood at $51800.5 (down 50.92% YoY), and the FY2025 full-year result was $84687.5, changed N/A from the prior year.
- Inventory Average fell to $51800.5 in Q1 2026, from $64877.5 in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $105549.0 in Q1 2025 to a low of $51800.5 in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 644.91 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.73 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 3.15 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Quantum Biopharma | 13.00 Bn | 13.00 Bn | - | 51,800.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 51,800.50 |
| Dec 31, 2025 | 64,877.50 |
| Sep 30, 2025 | 77,245.50 |
| Jun 30, 2025 | 85,362.50 |
| Mar 31, 2025 | 105,549.00 |